These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19544554)

  • 1. The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
    Valdagni R; Scardino PT; Denis L
    Cancer; 2009 Jul; 115(13 Suppl):3035-8. PubMed ID: 19544554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive modeling in prostate cancer. Conclusions and reflections.
    Denis LJ; Gospodarowicz MK
    Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive modeling in prostate cancer. Proceedings of the 2008 European School of Oncology Inside Track Conference.
    Cancer; 2009 Jul; 115(13 Suppl):3035-162. PubMed ID: 19544553
    [No Abstract]   [Full Text] [Related]  

  • 4. Techniques and predictive models to improve prostate cancer detection.
    Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
    Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic approaches to outcome prediction in prostate cancer.
    Febbo PG
    Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
    Valdagni R; Rancati T; Fiorino C
    Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Nguyen CT; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomolecular markers of outcome prediction in prostate cancer.
    Lopergolo A; Zaffaroni N
    Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active surveillance for low-risk prostate cancer.
    Bangma CH; Bul M; van der Kwast TH; Pickles T; Korfage IJ; Hoeks CM; Steyerberg EW; Jenster G; Kattan MW; Bellardita L; Carroll PR; Denis LJ; Parker C; Roobol MJ; Emberton M; Klotz LH; Rannikko A; Kakehi Y; Lane JA; Schröder FH; Semjonow A; Trock BJ; Valdagni R
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):295-302. PubMed ID: 22878262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European School of Oncology: 20 years of cancer education and a contribution to European Guidelines of Oncology.
    Costa A; Gatzemeier W
    Surg Oncol Clin N Am; 2001 Oct; 10(4):781-94, viii. PubMed ID: 11641090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive models in diagnosing indolent cancer.
    Bangma CH; Roobol MJ; Steyerberg EW
    Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision support systems for morphology-based diagnosis and prognosis of prostate neoplasms: a methodological approach.
    Montironi R; Cheng L; Lopez-Beltran A; Mazzucchelli R; Scarpelli M; Bartels PH
    Cancer; 2009 Jul; 115(13 Suppl):3068-77. PubMed ID: 19544548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive models of toxicity in external radiotherapy: dosimetric issues.
    Fiorino C; Rancati T; Valdagni R
    Cancer; 2009 Jul; 115(13 Suppl):3135-40. PubMed ID: 19544542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings.
    Pop GH; Fesperman SF; Ball DA; Yeung LL; Vieweg J; Dahm P
    J Urol; 2009 Aug; 182(2):674-8; discussion 678-9. PubMed ID: 19535105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal therapy in prostate cancer: future trends.
    Barqawi A; Crawford ED
    BJU Int; 2005 Feb; 95(3):273-4. PubMed ID: 15679774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and treatment of prostate cancer--it's diversity and future prospects].
    Ogawa O
    Hinyokika Kiyo; 2001 Feb; 47(2):131-8. PubMed ID: 11280887
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive modeling in prostate cancer: a conference summary.
    Valdagni R; Scardino PT; Denis L; Kattan MW
    Eur Urol; 2009 Feb; 55(2):300-2. PubMed ID: 18834662
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive models in palliative care.
    Ripamonti CI; Farina G; Garassino MC
    Cancer; 2009 Jul; 115(13 Suppl):3128-34. PubMed ID: 19544541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for the identification of men at increased risk for prostate cancer.
    Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL
    J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europa Uomo: the European Prostate Cancer Coalition.
    Hudson T; Denis LJ
    Recent Results Cancer Res; 2007; 175():267-71. PubMed ID: 17432565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.